The tumor was identified as an
oligodendroglioma, a rare type of brain cancer.
该肿瘤被识别为少突胶质瘤,一种罕见的脑癌。
She underwent surgery to remove the
oligodendroglioma from her frontal lobe.
她接受了手术,从她的额叶中移除少突胶质瘤。
Radiation therapy is often used in conjunction with chemotherapy for treating
oligodendrogliomas.
放射疗法常与化疗联合用于治疗少突胶质瘤。
The patient's
oligodendroglioma had low-grade malignancy, which meant it grew slowly.
患者的少突胶质瘤是低度恶性,这意味着它生长缓慢。
Oligodendrogliomas typically affect adults between the ages of 30 and 50."
少突胶质瘤通常影响30至50岁的成年人。
Researchers continue to investigate potential genetic causes of
oligodendroglioma development.
研究人员继续调查可能导致少突胶质瘤发展的潜在遗传原因。
The prognosis for patients with
oligodendroglioma varies depending on the tumor's grade.
少突胶质瘤患者预后取决于肿瘤的等级。
After treatment, the patient showed significant improvement in symptoms related to the
oligodendroglioma.
治疗后,患者与少突胶质瘤相关的症状明显改善。
Chemotherapy can sometimes cause side effects such as nausea when treating
oligodendroglioma.
在治疗少突胶质瘤时,化疗有时会引起恶心等副作用。
Long-term follow-up is essential for patients diagnosed with
oligodendroglioma due to its tendency to recur.
由于少突胶质瘤有复发的趋势,长期随访对于诊断出此病的患者至关重要。
未经许可,严禁转发。QQ交流群:688169419